Bioventix's (LON:BVXP) Dividend Will Be £0.68
Mar 29
U.K. (FTSE) Biotech Industry Analysis
UpdatedMay 08, 2024
DataAggregated Company Financials
Companies26
- 7D3.8%
- 3M-7.1%
- 1Y-23.3%
- YTDn/a
In the last week, the Biotech industry is up 3.8%, with Genus up 4.5%. In contrast, the industry has lost 23% in the last 12 months. Looking forward, earnings are forecast to grow by 25% annually.
Industry Valuation and Performance
Has the U.K. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 08 May 2024 | UK£3.0b | UK£836.5m | -UK£299,573,175.48 | 31.5x | -10x | 3.6x |
| Fri, 05 Apr 2024 | UK£3.1b | UK£903.1m | -UK£201,704,057.31 | 28.3x | -15.2x | 3.4x |
| Sun, 03 Mar 2024 | UK£3.0b | UK£897.8m | -UK£203,905,345.05 | 33x | -14.9x | 3.4x |
| Tue, 30 Jan 2024 | UK£6.4b | UK£1.3b | -UK£245,261,938.00 | 38.3x | -26.1x | 5x |
| Thu, 28 Dec 2023 | UK£6.3b | UK£1.3b | -UK£244,911,978.00 | 38.5x | -25.9x | 5x |
| Sat, 25 Nov 2023 | UK£6.3b | UK£1.3b | -UK£245,889,244.00 | 37.1x | -25.5x | 4.9x |
| Mon, 23 Oct 2023 | UK£6.5b | UK£1.3b | -UK£251,206,798.00 | 39.3x | -25.9x | 5.1x |
| Wed, 20 Sep 2023 | UK£6.6b | UK£1.3b | -UK£207,617,206.00 | 23.6x | -32x | 5.2x |
| Fri, 18 Aug 2023 | UK£6.6b | UK£1.3b | -UK£207,806,552.00 | 23.6x | -32x | 5.3x |
| Sun, 16 Jul 2023 | UK£6.8b | UK£1.3b | -UK£207,414,117.00 | 23.7x | -32.8x | 5.4x |
| Tue, 13 Jun 2023 | UK£7.0b | UK£1.3b | -UK£206,397,177.00 | 23x | -33.9x | 5.6x |
| Thu, 11 May 2023 | UK£7.0b | UK£1.3b | -UK£204,951,088.00 | 24x | -34.1x | 5.5x |
| Sat, 08 Apr 2023 | UK£7.2b | UK£1.2b | -UK£154,069,522.00 | 24.2x | -46.6x | 5.8x |
| Mon, 06 Mar 2023 | UK£7.5b | UK£1.2b | -UK£156,724,693.00 | 26.8x | -48.2x | 6.1x |
| Wed, 01 Feb 2023 | UK£7.4b | UK£1.2b | -UK£146,652,649.00 | 27.9x | -50.7x | 6.4x |
| Fri, 30 Dec 2022 | UK£7.5b | UK£1.2b | -UK£138,840,580.00 | 27.5x | -54.1x | 6.5x |
| Sun, 27 Nov 2022 | UK£7.7b | UK£1.2b | -UK£139,203,033.00 | 24.4x | -55.6x | 6.7x |
| Tue, 25 Oct 2022 | UK£6.9b | UK£1.2b | -UK£150,705,336.00 | 26x | -45.9x | 6x |
| Thu, 22 Sep 2022 | UK£7.5b | UK£1.2b | -UK£180,125,519.00 | 26.4x | -41.8x | 6.5x |
| Sat, 20 Aug 2022 | UK£7.6b | UK£1.1b | -UK£203,428,822.00 | 37.1x | -37.2x | 6.8x |
| Mon, 18 Jul 2022 | UK£6.8b | UK£1.1b | -UK£202,968,472.00 | 34.1x | -33.4x | 6.1x |
| Wed, 15 Jun 2022 | UK£6.6b | UK£1.1b | -UK£160,271,959.00 | 35.5x | -41.2x | 5.9x |
| Fri, 13 May 2022 | UK£6.8b | UK£1.1b | -UK£146,046,206.00 | 35.1x | -46.8x | 6.1x |
| Sun, 10 Apr 2022 | UK£7.6b | UK£1.1b | -UK£91,993,248.00 | 41.6x | -82.7x | 7x |
| Tue, 08 Mar 2022 | UK£7.5b | UK£1.1b | -UK£132,369,203.00 | 29.6x | -56.6x | 6.9x |
| Thu, 03 Feb 2022 | UK£9.2b | UK£1.1b | -UK£119,727,223.00 | 40.4x | -76.5x | 8.4x |
| Sat, 01 Jan 2022 | UK£11.5b | UK£1.1b | -UK£120,779,727.00 | 57.3x | -94.9x | 10.6x |
| Mon, 29 Nov 2021 | UK£11.2b | UK£1.1b | -UK£123,066,197.00 | 63.1x | -91.3x | 10.3x |
| Wed, 27 Oct 2021 | UK£12.4b | UK£1.1b | -UK£148,281,370.00 | 71.2x | -83.8x | 11.3x |
| Fri, 24 Sep 2021 | UK£12.5b | UK£1.1b | -UK£118,573,625.00 | 72.3x | -105.1x | 11.3x |
| Sun, 22 Aug 2021 | UK£12.4b | UK£1.0b | -UK£172,541,949.91 | 31.5x | -71.9x | 12.1x |
| Fri, 09 Jul 2021 | UK£11.2b | UK£1.0b | -UK£172,541,949.91 | 30.1x | -65x | 11x |
Price to Earnings Ratio
-68.3x
Current Industry PE
- Investors are pessimistic on the British Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 7.4x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
- Revenues have also declined 6.3% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Biotech compare with similar industries?
| GB Market | 1.96% | |
| Healthcare | 1.89% | |
| Biotech | 3.82% | |
| Biotech | 3.82% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GNS Genus | UK£18.86 | 4.5% +UK£53.8m | -26.7% | PE37x | |
| OXB Oxford Biomedica | UK£3.16 | 14.3% +UK£39.5m | -21.2% | PS3.5x | |
| PRTC PureTech Health | UK£2.22 | 2.8% +UK£16.7m | 2.3% | PS225.5x | |
| FARN Faron Pharmaceuticals Oy | UK£1.55 | 6.9% +UK£7.2m | -50.5% | PE-4.2x | |
| SCLP Scancell Holdings | UK£0.094 | 5.4% +UK£3.9m | -39.4% | PE-8.1x |